Astellas Pharma Inc
OTC:ALPMY

Watchlist Manager
Astellas Pharma Inc Logo
Astellas Pharma Inc
OTC:ALPMY
Watchlist
Price: 14.33 USD 1.27% Market Closed
Market Cap: $25.7B

Profitability Summary

Astellas Pharma Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Astellas Pharma Inc

Margins Comparison
Astellas Pharma Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
JP
Astellas Pharma Inc
TSE:4503
4T JPY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
529.7B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
277.3B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.9B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
222B CHF
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
96.9B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Astellas Pharma Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
JP
Astellas Pharma Inc
TSE:4503
4T JPY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
529.7B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
277.3B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.9B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
222B CHF
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
96.9B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Astellas Pharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate